Uric Acid Lowering Seaweed Oligosaccharide Ingredient Production Service
Inquiry

Uric Acid Lowering Seaweed Oligosaccharide Ingredient Production Service

At CD BioGlyco, we recognize the increasing global demand for natural, evidence-based solutions to manage hyperuricemia, a key precursor to gout and a factor in metabolic syndrome. Our uric acid-lowering seaweed oligosaccharide ingredient production service is a cutting-edge offering designed to meet this demand. It focuses on the customized, scalable production of high-purity seaweed oligosaccharides, which are gaining significant traction in the nutraceutical and functional food industries due to their proven bioactivity.

Key Technologies

  • Customized Enzymatic Hydrolysis
    We employ a proprietary library of highly specific polysaccharide lyases and glycoside hydrolases, including specialized agarases, alginases, and fucoidanases. This enzymatic approach allows for the targeted cleavage of high molecular weight polysaccharides into oligosaccharides with a defined degree of polymerization (DP) and specific, bioactive structural motifs.
  • Advanced Purification Techniques
    We utilize high-resolution separation techniques such as membrane filtration, ion-exchange chromatography, and size exclusion chromatography (SEC). These methods allow us to meticulously separate and purify the target oligosaccharide fractions, removing residual proteins, salts, and unreacted polymers, thus ensuring a high-quality final product.

Targeted Uric Acid Management: Custom Seaweed Oligosaccharide Ingredient Production

CD BioGlyco is specifically tailored to the functional food and nutraceutical market, focusing on the anti-hyperuricemic potential of seaweed oligosaccharides. The efficacy of these compounds often stems from their ability to inhibit key enzymes in the uric acid production pathway, such as xanthine oxidase, and/or to enhance uric acid excretion. Neoagarooligosaccharides (NAOs) derived from agar have exhibited significant xanthine oxidase inhibitory activity, thus reducing the production of uric acid. Mannuronate oligosaccharides (MOS) and guluronate oligosaccharides (GOS) derived from alginate effectively reduce serum uric acid levels, often by promoting uric acid excretion and exhibiting anti-inflammatory properties that mitigate symptoms associated with hyperuricemia.

Our primary service is providing clients with seaweed oligosaccharide raw materials that are customized to their specific application needs. This customization includes:

  • Tailored Degree of Polymerization (DP): We precisely control the hydrolysis to achieve a target DP range, as this heavily influences solubility, bioavailability, and biological activity.
  • Purity and Concentration: We deliver high-purity grades that meet stringent industry standards for your formulation development.
  • Structural Modification: We explore minor structural modifications, such as specific sulfation or acetylation patterns, to enhance the desired bioactivity profile, based on client project goals and target applications.

Workflow

1. Source Biomass Selection and Pre-treatment

This initial stage involves careful selection of the most appropriate seaweed species (e.g., red, brown, or green algae) known for high yields of target polysaccharides. The biomass undergoes rigorous quality control, followed by optimized washing, drying, and grinding processes to prepare it for efficient extraction.

2. Target Polysaccharide Extraction

We employ advanced extraction methods, such as enzyme-assisted extraction (EAE) or optimized mild hot-water and acid/alkaline processes. This step isolates the high molecular weight precursor polysaccharides (e.g., agar, alginate, fucoidan) from the prepared seaweed biomass, maximizing yield while minimizing degradation of the complex polymer structure.

3. Controlled Depolymerization

The extracted polysaccharide is subjected to our core technologies—precision enzymatic or controlled chemical hydrolysis. The reaction conditions (enzyme concentration, pH, temperature, time) are precisely tuned based on the client's specifications for the desired DP and targeted bioactivity profile, leading to the generation of the functional oligosaccharides.

4. Fractionation and High-Purity Isolation

The resulting mixture of oligosaccharides and residual byproducts is processed through our advanced purification train. This step uses techniques like membrane separation and chromatography to remove impurities and isolate the target oligosaccharide fraction with the required purity and molecular weight range, which is critical for their biological activity.

5. Detailed Structural and Activity Validation

Before final formulation, the isolated oligosaccharide fraction undergoes comprehensive structural analysis using our advanced analytical tools to confirm molecular identity, purity, and DP distribution. Furthermore, its uric acid-lowering activity is validated via relevant in vitro assays, ensuring the ingredient meets the performance criteria.

6. Final Ingredient Formulation

The high-purity oligosaccharide product is dried (e.g., lyophilized or spray-dried) and formulated into the final ingredient format (powder, solution) according to client specifications. A final battery of quality assurance tests, including stability, microbial load, and heavy metal analysis, confirms the product's safety and quality, ready for commercial application.

Publication Data

DoI: 10.3390/md16120472

Journal: Mar Drugs

IF: 5.4

Published: 2018

Results: This study investigates the ameliorative effect and hepatorenal protective role of fucoidan from Laminaria japonica on adenine-induced hyperuricemic mice. Mice were administered different doses of fucoidan, allopurinol, or a vehicle control. Results showed fucoidan significantly reduced serum uric acid levels via dual regulation: inhibiting hepatic adenosine deaminase and xanthine oxidase activities to decrease urate production, and downregulating renal urate transporter 1 expression to promote urate excretion. Additionally, fucoidan reversed adenine-induced hepatorenal dysfunction, restored normal levels of antioxidant indicators, and suppressed NF-κB p65 activation to alleviate inflammatory damage. The findings demonstrate that fucoidan from Laminaria japonica is a potential therapeutic agent for hyperuricemia, possessing both uricostatic and uricosuric effects.

Fig.1 Fucoidan repressed the expression and phosphorylation of NF-κB protein in the kidney of mice.Fig.1 Fucoidan repressed adenine-induced expression and phosphorylation of NF-κB protein in the kidney of mice. (Zhang, et al., 2018)

Applications

  • Inhibition of Cancer Cell Proliferation
    Oligosaccharides can interfere with signaling pathways necessary for cancer cell growth and the formation of new blood vessels that supply tumors, effectively starving the malignant tissue.
  • Induction of Apoptosis
    Certain oligosaccharide structures selectively trigger programmed cell death in various cancer cell lines, offering a targeted mechanism of action.
  • Enhancing Innate Immunity
    Oligosaccharides are known to stimulate key immune cells, such as macrophages and natural killer (NK) cells, promoting the production of beneficial cytokines that orchestrate an effective immune response.
  • Gut Microbiota Modulation
    They act as prebiotics, selectively promoting the growth of beneficial gut bacteria. A healthy gut microbiota is intimately linked to systemic immune function, contributing to a balanced and robust immune system.

Advantages

  • Glycoscience Leadership
    Our deep understanding of structure-function relationships ensures the design of an oligosaccharide molecule that delivers maximum bioactivity for uric acid management, not just a standard hydrolysis product.
  • Proprietary Enzymatic Development
    Our exclusive library of high-specificity glycan-cleaving enzymes ensures a highly controlled and reproducible production process, leading to a consistently pure ingredient with a tightly defined molecular weight profile.
  • Scalability and Quality
    Our production facilities are designed for efficient, large-scale manufacturing, adhering to rigorous international quality standards. We guarantee seamless scale-up from R&D batches to industrial quantities without compromising the established product specifications.
  • Renewable and Sustainable Sourcing
    We prioritize sustainable sourcing of marine biomass, aligning your product with the growing consumer demand for environmentally responsible and natural ingredients.

Frequently Asked Questions

Can you customize the DP for our specific application?

Absolutely. DP is a critical factor in both solubility and bioactivity. We will work with you to define the optimal DP range and engineer the production process to produce an ingredient tailored precisely to your formulation and target mechanism.

Are there any concerns regarding heavy metals or contaminants in the raw seaweed source?

We operate under strict quality control protocols, including screening raw biomass from certified suppliers and implementing purification steps that effectively eliminate heavy metals and environmental contaminants. Our final QA reports provide complete assurance of safety and compliance.

Customer Review

"CD BioGlyco's service was transformative for our new line of metabolic support supplements. The precision of their enzymatic hydrolysis delivered an neoagarooligosaccharide fraction with a molecular weight profile that perfectly matched our target bioactivity. Their analytical support was exceptional, providing the robust data we needed for substantiation."

- A.W., R&D Director

"We chose CD BioGlyco for their clear scientific expertise, and they exceeded our expectations. The team was highly responsive in customizing the alginate oligosaccharide raw material to meet the specific solubility demands of our functional products."

- H.B., Innovative Functional Products

"The transition from lab-scale to commercial-scale production of our specialized Fucoidan Oligosaccharide was seamless. CD BioGlyco's scalability, coupled with their rigorous QA/QC process, drastically reduced our risk."

- E.J., Global Health Ingredient Manufacturer

Associated Services

CD BioGlyco is your dedicated partner for the development and large-scale production of high-performance, uric acid-lowering seaweed oligosaccharide ingredients. Leveraging decades of specialized expertise and advanced enzymatic technology, we deliver customized, high-purity, and scientifically validated ingredients that offer a natural solution for hyperuricemia management. Please feel free to contact us to learn more about how our custom service can be integrated into your next market-leading product.

Reference

  1. Zhang, D.; et al. Production inhibition and excretion promotion of urate by fucoidan from Laminaria japonica in adenine-induced hyperuricemic mice. Mar Drugs. 2018, 16(12): 472. (Open Access)
For research use only. Not intended for any clinical use.

Related Services

Contact Us
Top